Hansen Medical, Inc. 

(Public, NASDAQ:HNSN)   Watch this stock   
Find more results for HNSN
Nov 17, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 16, 2009
Q3 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin -441.92% -176.77%
Operating margin -438.45% -178.58%
EBITD margin - -169.24%
Return on average assets -82.77% -81.03%
Return on average equity -122.76% -110.46%
Employees 208 -

Address

308 North Bernardo Avenue
Mountain View, CA 94043
United States - Map
+1-650-4045800 (Phone)
+1-650-4045901 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Hansen Medical, Inc. discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Hansen Medical, Inc. discussions

  View all discussions »

Description

Hansen Medical, Inc. (Hansen Medical) develops, manufactures and sells generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Its Sensei Robotic Catheter System, or Sensei system, is designed to allow physicians to instinctively navigate flexible catheters with greater stability and control in interventional procedures. The Company’s focus is on electrophysiology (EP) procedures for the diagnosis and treatment of patients who suffer from abnormal heart rhythms, or arrhythmias, such as atrial fibrillation.

Officers and directors

Russell C. Hirsch M.D., Ph.D.
Chairman of the Board
Age: 46
Bio & Compensation - Reuters
Frederic H. Moll M.D.
President, Chief Executive Officer, Director
Age: 57
Bio & Compensation - Reuters
Steven M. Van Dick
Chief Financial Officer, Vice President - Finance and Administration
Age: 54
Bio & Compensation - Reuters
M. Sean Murphy Ph.D.
Senior Vice President - Operations
Age: 48
Bio & Compensation - Reuters
Daniel T. Wallace
Vice President - Regulatory and Clinical Affairs
Age: 41
Bio & Compensation - Reuters
Robert G. Younge
Chief Technical Officer
Age: 56
Bio & Compensation - Reuters
John G. Freund M.D.
Director
Age: 55
Bio & Compensation - Reuters
James M. Shapiro
Director
Age: 50
Bio & Compensation - Reuters
Christopher P. Lowe
Director
Age: 41
Bio & Compensation - Reuters
Joseph M. Mandato
Director
Age: 64
Bio & Compensation - Reuters